174 related articles for article (PubMed ID: 22217469)
21. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Muhtarova AA; Gergova RT; Mitov IG
J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
[TBL] [Abstract][Full Text] [Related]
22. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece.
Petinaki E; Kontos F; Pratti A; Skulakis C; Maniatis AN
Int J Antimicrob Agents; 2003 Jan; 21(1):67-70. PubMed ID: 12507840
[TBL] [Abstract][Full Text] [Related]
23. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.
Bingen E; Fitoussi F; Doit C; Cohen R; Tanna A; George R; Loukil C; Brahimi N; Le Thomas I; Deforche D
Antimicrob Agents Chemother; 2000 Jun; 44(6):1453-7. PubMed ID: 10817692
[TBL] [Abstract][Full Text] [Related]
24. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
[TBL] [Abstract][Full Text] [Related]
26. Cloned
Oryaşın E; Bıyık HH; Tristram S; Bozdoğan B
Microb Drug Resist; 2020 Jul; 26(7):747-751. PubMed ID: 31971866
[No Abstract] [Full Text] [Related]
27. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
Colakoglu S; Alacam R; Hascelik G
Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
[TBL] [Abstract][Full Text] [Related]
29. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
[TBL] [Abstract][Full Text] [Related]
30. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
31. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
Zhao TM; Liu YN
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
[TBL] [Abstract][Full Text] [Related]
32. Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019.
Villalón P; Sáez-Nieto JA; Rubio-López V; Medina-Pascual MJ; Garrido N; Carrasco G; Pino-Rosa S; Valdezate S
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2295-2303. PubMed ID: 34046804
[TBL] [Abstract][Full Text] [Related]
33. Erythromycin resistance of Streptococcus pyogenes in Madrid.
Orden B; Perez-Trallero E; Montes M; Martínez R
Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
[TBL] [Abstract][Full Text] [Related]
34. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
35. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
[TBL] [Abstract][Full Text] [Related]
36. [Relation of pbp2B, ermB, ermA/B, mefA genes with resistance to penicillin and erythromycin among Streptococcus pneumoniae isolates from children].
Ding YF; Zhang JH; Mi ZH; Tao YZ; Qin L
Zhonghua Er Ke Za Zhi; 2005 May; 43(5):364-7. PubMed ID: 15924755
[TBL] [Abstract][Full Text] [Related]
37. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
39. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
[TBL] [Abstract][Full Text] [Related]
40. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
